Skip to main content

Molecular Basis of Histone Deacetylase Inhibitors as New Drugs for the Treatment of Inflammatory Diseases and Cancer

  • Protocol
Inflammation and Cancer

Part of the book series: Methods in Molecular Biology™ ((MIMB,volume 512))

Summary

Histone deacetylase inhibitors are potent inducers of growth arrest and apoptotic cell death and are currently in clinical studies for solid tumors. In addition, recent studies from our own group provide evidence for an anti-inflammatory potency of HDACi in vitro and in vivo by using various models of experimental colitis. Since inflammatory bowel disease in humans is associated with an increased risk of developing colorectal cancer, a therapeutic approach combining anti-inflammatory as well as antiprolif-erative properties is highly intriguing. Consequently, methods to further characterize the mechanisms involved include the direct analysis of the acetylation/deacetylation as well as the regulatory effect of histone deacetylase inhibitors on defined cell populations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Spencer, V. A. and Davie, J. R. (1999) Role of covalent modifications of histones in regulating gene expression Gene 240, 1–12.

    Article  CAS  PubMed  Google Scholar 

  2. Marks, P. A., Richon, V. M., and Rifkind, R. A. (2000) Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells J Natl Cancer Inst 92, 1210–1216.

    Article  CAS  PubMed  Google Scholar 

  3. Leoni, F., Zaliani, A., Bertolini, G., Porro, G., Pagani, P., Pozzi, P. , Dona, G., Fossati, G., Sozzani, S., Azam, T., Bufler, P. , Fantuzzi, G., Goncharov, I., Kim, S. H., Pomerantz, B. J., Reznikov, L. L., Siegmund, B., Dinarello, C. A., and Mascagni, P. (2002) The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines Proc Natl Acad Sci USA 99, 2995–3000.

    Article  CAS  PubMed  Google Scholar 

  4. Glauben, R., Batra, A., Fedke, I., Zeitz, M., Lehr, H. A., Leoni, F., Mascagni, P., Fan-tuzzi, D., Dinarello, C. A., and Siegmund, B. (2006) Histone hyperacetylation is associated with amelioration of experimental colitis in mice J Immunol 176, 5015–5022.

    CAS  PubMed  Google Scholar 

  5. Kiernan, R., Bres, V., Ng, R. W., Coudart, M. P. , El Messaoudi, S., Sardet, C., Jin, D. Y., Emiliani, S., and Benkirane, M. (2003) Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65 J Biol Chem 278, 2758–2766.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Glauben, R., Siegmund, B. (2009). Molecular Basis of Histone Deacetylase Inhibitors as New Drugs for the Treatment of Inflammatory Diseases and Cancer. In: Kozlov, S.V. (eds) Inflammation and Cancer. Methods in Molecular Biology™, vol 512. Humana Press. https://doi.org/10.1007/978-1-60327-530-9_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-530-9_21

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60327-529-3

  • Online ISBN: 978-1-60327-530-9

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics